They focused on posts discussing adverse events, specifically negative psychological and physical symptoms, linked to these medications
Advanced ultrasound skin tightening in Glasgow that stimulates collagen, lifts lax skin and improves firmness, while preserving natural facial volume and expression over time
The product is based on solid mechanistic science, but it lacks the clinical trial validation that pharmaceutical GLP-1 medications have in abundance
Decision framework: Start existing treatments (semaglutide or tirzepatide) if: Your health risks from obesity are significant and immediate (uncontrolled diabetes, severe sleep apnea, cardiovascular disease) You have access to approved therapies through insurance or can afford them You need proven, FDA-approved medications with established safety profiles Waiting 1-2+ years for retatrutide approval doesnt align with your health timeline Consider waiting if: Youre currently at a stable weight with controlled health conditions Youve tried semaglutide or tirzepatide and hit a plateau but tolerated them well Youre in a position to potentially enroll in a retatrutide clinical trial You understand waiting means continued health risks from obesity Dont wait if: You think retatrutide will be a magic bullet with no downsides Your doctor is recommending treatment now for medical reasons Youre using waiting for the next best thing as an excuse to avoid addressing the problem The lifestyle component is non-negotiable regardless of which medication you use: High protein intake (0.7-1g per pound of body weight daily) to preserve muscle during weight loss
Many Canadian insurance plans cap obesity medication coverage at $2,000-5,000 annually, which may not cover a full year of treatment
Beyond the pancreas: contrasting cardiometabolic actions of GIP and GLP1
